학술논문
Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure.
Document Type
Journal Article
Author
Source
Subject
*CLINICAL trials
*HEART failure
*GENE therapy
*ANGIOTENSIN II
*HYPERGLYCEMIA
*HEART failure treatment
*IMPLANTABLE cardioverter-defibrillators
*SKELETAL muscle
*
*
*
*
*
*
*
Language
ISSN
1388-9842
Abstract
This article continues a series of reports summarising recent research developments pertinent to the topic of heart failure. This is a summary of presentations made at scientific sessions of the American Heart Association in November 2000. Clinical studies of particular interest to people caring for patients with heart failure include Val-HeFT, AMIOVIRT and V-MAC. New data from β-blockers trials are reviewed, highlights from some important developments in post-infarction care, including MIRACL and FLORIDA, discussed and results of some early studies of gene therapy reported. [ABSTRACT FROM PUBLISHER]